Recognizing Progress in an Unprecedented Year

Thursday, December 3, 2020 | Virtual

California Life Sciences AssociationCalifornia Life Sciences Association

Rising Star


Pendulum Therapeutics (formerly Whole Biome) is pioneering an ability to identify novel bacteria and their potential for affecting human health, using proprietary high-resolution data analytical tools to identify specific micro-biomarkers and novel interventions for such diseases as, at present, Type 2 diabetes and irritable bowel syndrome.  The company has raised a total of $57 million in equity financing since its beginning, including a $35 million Series B financing which closed in May 2019, from leading life sciences financiers such as Sequoia Capital, True Ventures, Khosla Ventures, Mayo Foundation, AME Cloud Ventures and others. One of Pendulum Therapeutics core values is diversity, which is evidenced in its overall personnel makeup and particularly in its management team, building on, as is stated on its website, a foundation of integrity and kindness as part of its culture.